Lacrimal gland extranodal marginal zone B-cell lymphoma in the presence of amyloidosis
Amyloidosis is a protein metabolism disorder characterised by extracellular deposition of insoluble amorphous hyaline material. Orbital and ocular amyloid lesions account for only 4% of localised disease affecting the head and neck. Ocular adnexal lymphoma accounts for 1-2% of lymphoma, with lacrimal gland lymphomas being relatively uncommon. The most common form affecting the orbit is extranodal marginal zone lymphoma (EMZL) of mucosa-associated lymphoid tissue (MALT lymphoma). We report an extremely rare case of co-existent EMZL and amyloidosis of the lacrimal gland. Initial biopsy of the right lacrimal gland confirmed an EMZL with amyloid deposit, and a course of radiotherapy treatment was given. Recurrent lacrimal gland swelling developed within a year. Subsequent biopsy identified amyloidosis with scanty lymphoid tissue. To our knowledge, this is the first reported case of localised lacrimal gland amyloidosis of uncertain type with previous EMZL; the association described in this case report is not yet fully understood.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Orbit (Amsterdam, Netherlands) - 41(2022), 3 vom: 19. Juni, Seite 350-353 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chean, Chung Shen [VerfasserIn] |
---|
Links: |
---|
Themen: |
‘amyloidosis’ |
---|
Anmerkungen: |
Date Completed 17.05.2022 Date Revised 17.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/01676830.2020.1852578 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317803107 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM317803107 | ||
003 | DE-627 | ||
005 | 20231225164029.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/01676830.2020.1852578 |2 doi | |
028 | 5 | 2 | |a pubmed24n1059.xml |
035 | |a (DE-627)NLM317803107 | ||
035 | |a (NLM)33213206 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chean, Chung Shen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Lacrimal gland extranodal marginal zone B-cell lymphoma in the presence of amyloidosis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.05.2022 | ||
500 | |a Date Revised 17.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Amyloidosis is a protein metabolism disorder characterised by extracellular deposition of insoluble amorphous hyaline material. Orbital and ocular amyloid lesions account for only 4% of localised disease affecting the head and neck. Ocular adnexal lymphoma accounts for 1-2% of lymphoma, with lacrimal gland lymphomas being relatively uncommon. The most common form affecting the orbit is extranodal marginal zone lymphoma (EMZL) of mucosa-associated lymphoid tissue (MALT lymphoma). We report an extremely rare case of co-existent EMZL and amyloidosis of the lacrimal gland. Initial biopsy of the right lacrimal gland confirmed an EMZL with amyloid deposit, and a course of radiotherapy treatment was given. Recurrent lacrimal gland swelling developed within a year. Subsequent biopsy identified amyloidosis with scanty lymphoid tissue. To our knowledge, this is the first reported case of localised lacrimal gland amyloidosis of uncertain type with previous EMZL; the association described in this case report is not yet fully understood | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a ‘amyloidosis’ | |
650 | 4 | |a ‘lacrimal gland’ | |
650 | 4 | |a ‘lymphoma’ | |
700 | 1 | |a Sovani, Vishakha |e verfasserin |4 aut | |
700 | 1 | |a Boden, Ali |e verfasserin |4 aut | |
700 | 1 | |a Knapp, Christopher |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Orbit (Amsterdam, Netherlands) |d 1994 |g 41(2022), 3 vom: 19. Juni, Seite 350-353 |w (DE-627)NLM08276090X |x 1744-5108 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2022 |g number:3 |g day:19 |g month:06 |g pages:350-353 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/01676830.2020.1852578 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2022 |e 3 |b 19 |c 06 |h 350-353 |